The companies may be comfortable with the PBAC considering their medicines, but the committee can not just do whatever it likes. If companies are not comfortable, they have all the legal power to stop the committee by invoking the legal protections they have over their proprietary information. …
Companies have all the power in this process, if they choose to use it
July 21, 2025 Latest NewsBioPharmaNews of the DayComment
Latest Video
New Stories
-
Another day, and another example of our system's shortcomings
July 21, 2025 - - Latest News -
Companies have all the power in this process, if they choose to use it
July 21, 2025 - - Latest News -
Trump says countries will avoid tariffs if manufacturing returns to the US
July 21, 2025 - - Latest News -
Mesoblast updates investors on the succesful US launch of cell medicine
July 20, 2025 - - Australian Biotech -
Company refuses FDA request to halt distribution of gene therapy
July 20, 2025 - - Latest News -
Australian researcher awarded Gilead Sciences global grant to explore novel approach in breast cancer
July 18, 2025 - - Latest News -
The 'Dispatched' Week in Review Podcast - 17 July
July 17, 2025 - - Podcast